Aura Biosciences
Develops bel-sar, a virus-like drug conjugate for organ-preserving cancer treatment.
$7.40
After-hours close+0.01 (+0.07%)
At close$7.40(−3.96%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.37 | — | — |
| Aug 2026 | −$0.38 | −$0.48 | −28.0% |
| Aug 2026 | −$0.38 | −$0.48 | −28.0% |
| May 2026 | −$0.40 | −$0.50 | −25.0% |
| Mar 2026 | −$0.43 | −$0.37 | +14.0% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Nov 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.37 | — | — | — | — | — |
| Aug 12, 2026 | −$0.38 | −$0.48 | −28.0% | — | — | — |
| Aug 11, 2026 | −$0.38 | −$0.48 | −28.0% | — | — | — |
| May 11, 2026 | −$0.40 | −$0.50 | −25.0% | — | — | — |
| Mar 30, 2026 | −$0.43 | −$0.37 | +14.0% | — | — | — |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | ||||||
| Nov 13, 2025 | ||||||
| Aug 13, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 24, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 23, 2022 | ||||||
| Nov 24, 2021 | ||||||
| Nov 1, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||